Fighting drug resistance with tailored combinations of antibiotics that kill microbes in different ways

January 11, 2017, Agency for Science, Technology and Research (A*STAR), Singapore
Fighting drug resistance with tailored combinations of antibiotics that kill microbes in different ways
Using colistin in combination with other antibiotics (rifampicin, tigecycline and meropenem) proved more effective in treating multidrug-resistant bacteria than applying the antibiotics individually. That is because the four antibiotics used had different killing mechanisms against microbes. Credit: Ref 1. Copyright (2016), with permission from Elsevier.

Triple-pronged attacks on microbes that cause life-threatening lung infections are much more effective than individual antibiotics, A*STAR researchers have found. Using cocktails of antibiotics is promising for addressing the rising menace of multidrug-resistant microbes.

Multidrug-resistant bacteria are the plague of the twenty-first century and are predicted to become the leading cause of death by 2050, surpassing even cancer and diabetes, says Desmond Heng Wen Chien of the A*STAR Institute of Chemical and Engineering Sciences. "It is imperative that we act now to stem the rise of antimicrobial resistance and to mitigate its impact with more robust, but safer therapies," he urges.

In particular, superbugs that cause respiratory are posing an increasingly ominous threat. They have dire clinical outcomes, with mortality rates reaching as high as 80 per cent for some infections. Furthermore, they have begun to spread from hospitals to the community at large. The last line of defense against such superbugs is the highly toxic antibiotic known as colistin, but there are recent reports of infections that are resistant to even that.

Now, Heng and his co-workers have shown that using three tailored combinations of colistin with two other antibiotics can effectively combat lung infections caused by multidrug-resistant superbugs. They found that all three formulations were highly effective against the multidrug-resistance pathogens in the laboratory. In concocting these combinations, the team drew on initial laboratory screening data and existing clinical data to obtain more effective and robust formulations.

Since the four antibiotics used in these cocktails employ different mechanisms to kill bacteria (see image), their ternary combinations exhibit significant synergistic and additive effects. Their combined effectiveness is much greater than their individual application. The triple-killing mechanism of these ternary combinations, and the potential to rotate the three combinations during therapy, makes it much harder for microbes to develop resistance to them. Using other antibiotics in combination with colistin has the added advantage that it reduces the amount of colistin needed and the toxicity to the patient.

The are easy to self-administer. "Our formulations are designed to be delivered into the deep-lung region by a portable, easy-to-use dry-powder inhaler, which is faster, more direct and more convenient than other modes of treatment," says Heng.

The team intends to conduct in vivo studies in animals and then humans in collaboration with hospital clinicians. The researchers note that the same strategy could be applied to fight other drug-resistant bacteria.

Explore further: Research on new, rapid screening test identifies potential therapies against drug-resistant bacteria

More information: Sie Huey Lee et al. Tailored Antibiotic Combination Powders for Inhaled Rotational Antibiotic Therapy, Journal of Pharmaceutical Sciences (2016). DOI: 10.1016/j.xphs.2016.02.007

Related Stories

Research on new, rapid screening test identifies potential therapies against drug-resistant bacteria

November 10, 2016
Researchers at the National Institutes of Health's National Center for Advancing Translational Sciences (NCATS), Clinical Center and National Institute of Allergy and Infectious Diseases (NIAID) have created a new way to ...

Research sheds light on mechanism that leads to drug-resistant superbugs

September 29, 2016
Drug-resistant organisms, or so-called "superbugs," are a growing public health threat because "last-resort" therapeutics-employed only when other drugs fail to kill an infection-are failing. A University of Georgia-led research ...

New resistance gene found in 'high risk' multidrug-resistant pathogen

July 12, 2016
A team of Italian investigators has discovered a new variant of an emerging antibiotic resistance mechanism. The new variant, dubbed mcr-1.2, confers resistance to colistin, a last-resort antibiotic against multidrug-resistant ...

Q&A: Superbug precursor found in US again

July 11, 2016
A New York City patient was infected with bacteria that had a special type of resistance to antibiotics last year, the earliest known case in the U.S. of bacteria that could lead to a superbug impervious to medications.

Study finds smaller community hospitals antibiotics use similar to large hospitals

October 13, 2016
Bolstering antimicrobial stewardship programs to ensure appropriate use of antibiotics in smaller community hospitals is necessary to combat the global threat of antibiotic-resistant bacteria known as superbugs, according ...

Recommended for you

New study offers insights on genetic indicators of COPD risk

January 16, 2018
Researchers have discovered that genetic variations in the anatomy of the lungs could serve as indicators to help identify people who have low, but stable, lung function early in life, and those who are particularly at risk ...

Previous influenza virus exposures enhance susceptibility in another influenza pandemic

January 16, 2018
While past exposure to influenza A viruses often builds immunity to similar, and sometimes different, strains of the virus, Canadian researchers are calling for more attention to exceptions to that rule.

Don't hold your nose and close your mouth when you sneeze, doctors warn

January 15, 2018
Pinching your nose while clamping your mouth shut to contain a forceful sneeze isn't a good idea, warn doctors in the journal BMJ Case Reports.

New antifungal provides hope in fight against superbugs

January 12, 2018
Microscopic yeast have been wreaking havoc in hospitals around the world—creeping into catheters, ventilator tubes, and IV lines—and causing deadly invasive infection. One culprit species, Candida auris, is resistant ...

Dengue takes low and slow approach to replication

January 11, 2018
A new study reveals how dengue virus manages to reproduce itself in an infected person without triggering the body's normal defenses. Duke researchers report that dengue pulls off this hoax by co-opting a specialized structure ...

Different strains of same bacteria trigger widely varying immune responses

January 11, 2018
Genetic differences between different strains of the same pathogenic bacterial species appear to result in widely varying immune system responses, according to new research published in PLOS Pathogens.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.